1. Market Research
  2. > Pharmaceutical Market Trends
  3. > China Pharmaceutical Raw Materials Market Report

China Pharmaceutical Raw Materials Market Report

  • July 2013
  • -
  • Beijing Zeefer Consulting Ltd
  • -
  • 54 pages

This report presents a clear picture about the overall development of pharmaceutical raw materials market in China and the trend in recent years based on detailed data analysis. This report includes the analysis on the pharmaceutical raw materials market size and market share in China, the study on major hot areas in this market, introduction of key data and the comparison of top 10 enterprises in terms of sales revenue and market share, the detailed description of the import and export…

This report covers following sections.

- Market Size
Based on Zeefer's China Market Size Formula, by the analysis on market size, industry sales revenue and domestic output in 2009-2012, this report presents a picture of the real development of China market and changes in the overall market size.

- Hot Areas
Based on the comparison and analysis on production volume and import in different provinces or cities, this report points out those hot areas in this market deserve most attention.

- Top 10 Enterprises
Based on the comparison and analysis on top 10 leading enterprises in terms of sales revenue, market share and number of employees, the report shows their market positions in China. Additionally, this report lists basic contact information of the top 10 leading enterprises.

- Market Share and Market Structure
This report analyzes the market share distribution by segments based on enterprises nature (leading enterprises, foreign enterprises, state-owned and private enterprises), imports and regional markets in China in terms of sale revenue, profitability, production volume, number of enterprises and the value of imports... The report offers data on the market shares of imported products, foreign enterprises and enterprises in other forms. It also offers a comparison of profitability by forms of enterprise ownership, presents a picture of the market share of leading enterprises and the distribution of major regional markets in China. In addition, the report figures out the structure and concentration ratio of the current pharmaceutical raw materials market in China by means of Bain's Market Structure Classification and Index of CR4.

- Import and Export
In this section, the report includes the main source countries / regions of imported products for China and their market shares, the domestic destinations of imported products in China and shares for these destinations, major export destinations (countries or regions) for Chinese products and shares of these destinations, major origins of the exported products and their shares.

- Industry Standards
The report lists relevant national standards and/or industrial standards concerning pharmaceutical raw materials products generally accepted in China, including standard names both in Chinese and English as well as their unified code numbers.

- Major Importers
The report lists 10 major importers for pharmaceutical raw materials products in China and provides their contact information such as company name, address, website, telephone number and fax number.

- Key Statistics
Based on the concise analysis on the sales revenue, production volume, number of enterprises, total profit, total loss, total assets, return on the asset and profit margin as well as other key statistics, the report presents the current situation, the growth rate and profitability of this industry in China.

* Product definition
Pharmaceutical raw materials products mentioned in this report is a general concept, it shall include the following products:
Classified by the United Nation's Central Product Classification (CPC)
CPC Code: 22980, 23210, 34140, 34150, 352
Based on the United Nation's Central Product Classification (CPC Version 1.1), pharmaceutical raw materials refer to lactose and lactose syrup; glucose and glucose syrup; fructose and fructose syrup; invert sugar; sugars and sugar syrups n.e.c.; artificial honey; caramel; carboxylic acids and their anhydrides, halides, peroxides and peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives, except salicylic acid and its salts and esters and their salts; amine-function compounds; oxygen-function amino-compounds, except lysine and its esters and salts thereof and glutamic acid and its salts; ureines and their derivatives and salts thereof; carboxyimide-function compounds and imine-compounds; nitrile-function compounds; diazo-, azo- or azoxy-compounds; organic derivatives of hydrazine or of hydroxylamine; compounds with other nitrogen function; pharmaceutical products.

Table Of Contents

China Pharmaceutical Raw Materials Market Report
Chapter 1 Product Definition 1
Chapter 2 Market Size 5
2.1 Analysis On The Pharmaceutical Raw Materials Market Size 5
2.2 Analysis On The Changes In Pharmaceutical Raw Materials Production Volume In Recent Years 7
2.3 An Overview On Chinese Economy 8
Chapter 3 Hot Spots For Pharmaceutical Raw Materials Products Across China 12
Chapter 4 Industry Overview 14
4.1 A Summary On The Industry 14
4.2 An Analysis On The Profitability Of The Industry 15
Chapter 5 Analysis On Import and Export 18
5.1 An Overview On The Import and Export 18
5.2 A Detailed Analysis On Import and Export Of Pharmaceutical Raw Materials Products 20
5.2.1 Analysis On Major Countries Of Origin For The Imported Pharmaceutical Raw Materials Products 20
5.2.2 Analysis On The Major Flow Destinations Inside China 22
5.2.3 Analysis On Major Export Destinations 23
5.2.4 Analysis On Major Origins In China 24
Chapter 6 The Market Share 26
6.1 Analysis On The Concentration Of Corporate Sales Revenue 26
6.1.1 Analysis On The Concentration Of Sales Revenue From Leading Enterprises 26
6.1.2 Comparative Analysis On Sales Revenue From Top 10 Enterprises With Industry Average 28
6.2 Analysis On The Concentration By Area In Terms Of The Market Share 30
6.2.1 Analysis On Concentration Of Regional Sales Revenue 30
6.2.2 Analysis On The Concentration Of Regional Production Volume 31
6.3 Market Position Of Foreign Enterprises And The Trend In Recent Years 33
6.3.1 Changes In The Shares Of Foreign Enterprises In Terms Of The Numbers And The Comparison Of Foreign Enterprises And Enterprises Of Other Ownership 33
6.3.2 Changes In The Shares Of Sales Revenue From Foreign Enterprises And Comparison With That From Enterprises Of Other Ownership 35
6.3.3 Profitability Of Foreign Enterprises And Comparison With Enterprises Of Other Ownership 37
6.4 Analysis On The Market Share Of Imported Products And Relevant Variations In Recent Years 39
Chapter 7 Top 10 Enterprises 41
7.1 Cspc Pharmaceutical Group Limited 41
7.2 Northeast Pharmaceutical Group Co., Ltd. 41
7.3 Yishui Dadi Corn Development Co., Ltd. 42
7.4 Cspc Zhongrun Pharmaceutical (Inner Mongolia) Co., Ltd. 43
7.5 Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory 43
7.6 Zhejiang Nhu Co., Ltd. 44
7.7 Anhui Bbca Group Co., Ltd. 45
7.8 Tianjin Jinyao Group Co., Ltd. 45
7.9 Shandong Weifang Rainbow Chemical Co., Ltd. 46
7.10 Shandong Ruiying Pioneer Pharmaceutical Co., Ltd. 46
Chapter 8 Product Standard Systems 48
Chapter 9 List Of Major Importers 49

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.